Search results
Results From The WOW.Com Content Network
AMB-FUBINACA (also known as FUB-AMB and MMB-FUBINACA [3]) is an indazole-based synthetic cannabinoid that is a potent agonist for the cannabinoid receptors, with K i values of 10.04 nM at CB 1 and 0.786 nM at CB 2 and EC 50 values of 0.5433 nM at CB 1 and 0.1278 nM at CB 2, [4] and has been sold online as a designer drug.
In 2021, MDMB-4en-PINACA was the most common synthetic cannabinoid identified by the Drug Enforcement Administration in the United States. [10] MDMB-4en-PINACA differs from 5F-MDMB-PINACA due to replacement of 5-fluoropentyl with a pent-4-ene moiety (4-en).
Synthetic Cannabinoids are illegal in New Zealand, it is classified as a Class A controlled drug. [206] The New Zealand Parliament passed a law in July 2013 banning the sale of legal highs in dairies and supermarkets, but allowing some "low risk" drugs to continue to be sold through speciality licensed shops. [207]
Country/Territory Recreational Medical Notes Afghanistan Illegal Illegal Main article: Cannabis in Afghanistan Production banned by King Zahir Shah in 1973. Albania Illegal Legal Main article: Cannabis in Albania Prohibited but plants highly available throughout the country and law often unenforced. On 21 July 2023 the Albanian Parliament voted 69–23 to legalize medical cannabis. Algeria ...
Recreational pot sales are nearing reality in Ohio. The state Division of Cannabis Control began accepting applications Friday for new dual licenses that will allow existing medical marijuana ...
Timeline of Gallup polls in US on legalizing marijuana. [1]In the United States, cannabis is legal in 39 of 50 states for medical use and 24 states for recreational use. At the federal level, cannabis is classified as a Schedule I drug under the Controlled Substances Act, determined to have a high potential for abuse and no accepted medical use, prohibiting its use for any purpose. [2]
Even though hemp-derived products were federally legalized six years ago, products like delta-8 can still show up as marijuana on standard drug tests.
The legal cannabis industry in New York is expected to soar in 2025, with state regulators projecting the number of new licensed pot stores will more than double from 275 to more than 625.